ISHLT 2023 Annual Meeting Awards Showcase Advances in Treatment of Advanced Heart and Lung Disease
June 02, 2023 10:05 ET
|
International Society for Heart and Lung Transplantation
Chicago, IL, June 02, 2023 (GLOBE NEWSWIRE) -- The International Society for Heart and Lung Transplantation 43rd Annual Meeting & Scientific Sessions included more than 1,250 presentations on...
Medigene AG presents final Phase I data of TCR-T cell therapy MDG1011 in patients with high-risk blood cancers
April 24, 2023 05:00 ET
|
Medigene AG
MDG1011 was generally well tolerated in nine heavily pre-treated patients across three ascending dose levelsNo neurotoxicity or dose-limiting toxicities observedTwo out of nine patients showed early...
Medigene AG to present Phase I clinical data for MDG1011 with poster presentation at EBMT 2023 Annual Meeting
April 11, 2023 10:45 ET
|
Medigene AG
Martinsried/Munich, April 11, 2023. Medigene AG (Medigene, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid...
Medigene to present first pre-clinical data for MDG1015 with poster presentation at AACR 2023 Annual Meeting
March 16, 2023 05:00 ET
|
Medigene AG
Martinsried/Munich, March 16, 2023. Medigene AG (Medigene, FSE: MDG1, Prime Standard), an early stage immuno-oncology platform company focusing on the discovery and development of T cell...
ISHLT Annual Meeting & Scientific Sessions to Convene International Transplant Community Next Month
March 14, 2023 09:30 ET
|
International Society for Heart and Lung Transplantation
Chicago, IL, March 14, 2023 (GLOBE NEWSWIRE) -- The International Society for Heart and Lung Transplantation (ISHLT) will host its 43rd Annual Meeting & Scientific Sessions on 19-22 April, 2023...
Florida Cancer Specialists & Research Institute Contributing to Rapid Advancements in Breast Cancer Treatment
December 13, 2022 13:58 ET
|
Florida Cancer Specialists & Research Institute
Fort Myers, Florida, Dec. 13, 2022 (GLOBE NEWSWIRE) -- Florida Cancer Specialists & Research Institute, LLC (FCS) hematologists and medical oncologists were contributors to several presentations...
Secured Signing's CEO Gal Thompson Introduces Notary Queue and Snapshot to Its Remote Online Notarization and Digital Signature SaaS Platform
December 06, 2022 19:46 ET
|
Secured Signing
MOUNTAIN VIEW, Calif., Dec. 06, 2022 (GLOBE NEWSWIRE) -- Secured Signing today announced the latest product updates and enhancements across its Remote Online Notarization and Digital Signature...
AXIM Biotechnologies Publishes Study Highlighting Neutralizing Antibody Levels of Poor Vaccine Responders with a Third COVID-19 Vaccine Dose
July 12, 2022 09:00 ET
|
AXIM BIOTECHNOLOGIES, INC
SAN DIEGO, July 12, 2022 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an international healthcare solutions company, announced today their...
Florida Cancer Specialists & Research Institute Presents Clinical Research Results at 2022 ASCO® Annual Meeting
June 03, 2022 09:57 ET
|
Florida Cancer Specialists & Research Institute
Fort Myers, Florida, June 03, 2022 (GLOBE NEWSWIRE) -- Florida Cancer Specialists & Research Institute, LLS (FCS) physicians are presenting the outcomes of 33 clinical trials, the majority being...
BluChip NFT Marketplace Launches Its First NFT Auction of a One-of-a-Kind Keith Haring Subway Drawing on the BluChip NFT Auction Site
May 23, 2022 09:00 ET
|
BluChip
PALM SPRINGS, Calif., May 23, 2022 (GLOBE NEWSWIRE) -- BluChip today introduced its unique NFT Auction enabling the purchase of non-fungible tokens (NFTs) that are tethered to an original fine art...